Veeda Clinical Research Ltd - IPO

Veeda Clinical Research Ltd IPO Details

Initial public offering of up to [*] equity shares of face value of Rs. 2 each (The Equity Shares) of Veeda Clinical Research Limited (The Company or the Company or the Issuer) for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) (the Offer price) aggregating up to Rs. 831.60 crores (The Offer) comprising a fresh issue of [*] equity shares aggregating up to Rs. 331.60 crores (the Fresh Issue) and an offer for sale of up to [*] equity shares (The Offered Shares) aggregating up to Rs. 500 crores, comprising an offer for sale of up to [*] equity shares aggregating up to Rs. 8.08 crores by CX Alternative Investment Fund (CX AIF), up to [*] equity shares aggregating up to Rs. 90.19 crres by Arabelle Financial Services Limited (Arabelle), up to [*] equity shares aggregating up to Rs. 259.77 crores by Bondway Investments inc. (Bondway) and up to [*] equity shares aggregating up to Rs. 0.041 crores by Stevey International Corporation (Stevey, and together with CX AIF, Arabelle and Bondway, the Investor Selling Shareholders) and up to [*] equity shares aggregating up to Rs. 141.93 crores by Basil Private Limited (Basil or Promoter Selling Shareholder, and collectively with the investor selling shareholders referred to as the Selling Shareholders and such offer by selling shareholders, the Offer for Sale). This offer includes a reservation of up to [*] equity shares aggregating up to Rs. [*] (constituting up to [*]% of the post-offer paid-up equity share capital of the company) for purchase by eligible employees (The Employee Reservation Portion). The offer less the employee reservation portion is hereinafter referred to as the Net Offer. The company and the selling shareholders in consultation with the book running lead managers, may offer a discount of up to Rs. [*] of the offer price to eligible employees bidding in the employee reservation portion (Employee Discount). The offer would constitute at least [*]% of the post-offer paid-up equity share capital of the company.The face value of the equity share is Rs. 2 each and the offer price is [*] times the face value of equity shares.

Objective of issue

Repayment/Prepayment of Certain Indebtedness(including accrued interet) Availed by the Subsidiary. Funding Capital Expenditure Requirements of the Company. Investment in Subsidiary for Financing Capital Expenditure Requirements. Funding Further Acquisition of Equity Shares of Bioneeds. Funding Acquisition of Equity shares of Ingenuity BioSciences Pvt Ltd. Funding Working Capital Requirements of the Company. General Corporate Purposes.

Veeda Clinical Research Ltd Contact Details

Veeda Clinical Research Ltd, C-101 247 Park, L B S Marg, Vikhroli West, Mumbai-400083

Phone - 91-22-49186000

Fax - 91-22-49186060

Email - investor.relation@veedacr.com

Website - www.veedacr.com